U.S. General Merchandise and Department Stores Stock News

AMETEK (AME) is back in focus after its revenue growth, operating margin and free cash flow margins were highlighted as strengths, prompting investors to reassess the industrial stock’s positioning versus peers. See our latest analysis for AMETEK. Over the past year, AMETEK’s share price return has been supported by steady gains, with a 13.32% year to date share price return and a 33.60% 1 year total shareholder return suggesting momentum has been gradually building as investors reassess its...

In recent commentary, Novanta Inc. was flagged for below-average sales growth over the past two years and an outlook that points to uncertain demand ahead. An important concern is that the company’s earnings growth has lagged peers, raising fresh questions about how durable its business performance really is. We’ll now explore how these concerns about weaker sales and earnings momentum may reshape Novanta’s previously optimistic investment narrative. The latest GPUs need a type of rare...

Genpact (G) has drawn fresh attention after partnering with Nestlé Business Solutions to build a Global Capability Center in India, using agentic AI and process expertise to support Nestlé’s worldwide operations. See our latest analysis for Genpact. Despite the new Nestlé partnership and a recently affirmed quarterly dividend of $0.1875 per share, Genpact’s 1-year total shareholder return is down 30.66%, with year to date share price returns down 32.72%. However, the recent 7-day share price...

Atlanticus Holdings (ATLC) has attracted fresh attention after a recent period of strong share price gains, with the stock up 5.1% over the past month and 41.9% over the past 3 months. See our latest analysis for Atlanticus Holdings. Zooming out, the recent 5.1% 1 month share price return and 41.9% 3 month share price return come on top of a 51.7% year to date share price return and 94.1% 1 year total shareholder return, which indicates that momentum in Atlanticus Holdings may still be...

Five9 (FIVN) has drawn investor attention after a period of sharp recent gains, with the stock up about 32% over the past month and about 62% in the past 3 months. See our latest analysis for Five9. The recent surge in Five9's share price, including a 32.1% 30-day share price return and 62.1% 90-day share price return, contrasts with a 1-year total shareholder return that declined 5.1%. This suggests that momentum has picked up after a weaker longer-term experience for holders. If you are...

Progressive stock has pulled back recently after profitability concerns, yet over the last five years it has still delivered strong gains, leaving investors asking whether the current valuation now fairly reflects both that track record and the rising loss costs in its core insurance lines. A roughly 145% return over five years shows Progressive has created substantial shareholder value, which can make today’s price feel less like a clear bargain and more like a test of staying...

Saia stock has delivered a 111.0% total return over the past five years, yet its current checks lean toward the shares looking expensive rather than like a clear bargain. Over five years, a 111.0% return suggests Saia has already rewarded investors who stayed the course. This raises the bar for any new upside based purely on valuation. Recent analyst upgrades tied to strong earnings momentum and pricing power can support confidence in Saia's cash generation. However, any setback in demand or...

Xencor recently announced that Phase 1 results for XmAb819, its bispecific antibody for advanced clear cell renal cell carcinoma, were accepted for an oral presentation at the 2026 ESMO Congress, highlighting expansion-cohort data that informed the recommended Phase 3 dose. This recognition at a major oncology meeting, along with plans to begin a pivotal XmAb819 monotherapy study in 2027, underscores how Xencor’s antibody engineering platform is extending beyond inflammatory and autoimmune...

Smithfield Foods (SFD) stock has been drawing attention after recent price moves, including a 0.6% gain over the past day and a 4.5% rise over the past week, prompting closer scrutiny from investors. See our latest analysis for Smithfield Foods. At a share price of $25.77, Smithfield Foods shows short term momentum with a 7 day share price return of 4.46%. However, the 90 day share price return is down 11.14%, while the 1 year total shareholder return of 14.24% suggests recent gains are still...

Morgan Stanley recently reaffirmed its Equal Weight rating on Ingram Micro Holding and raised earnings forecasts alongside an improved view of the enterprise server market, while the company has already scheduled its second-quarter 2026 results call and webcast, which took place on July 30, 2026. Fresh analyst optimism around Ingram Micro's role in an enterprise server industry that is expected to expand very rapidly has coincided with the stock outperforming its Business Services peers...

Investor focus on Texas Pacific Land (TPL) is centering on the upcoming Q2 earnings report on August 5, 2026, as the company prepares to update the market on its profitability and capital allocation. See our latest analysis for Texas Pacific Land. Against this backdrop, Texas Pacific Land’s recent 30 day share price return of 17.27% and year to date share price return of 39.51% suggest building positive momentum. The 1 year total shareholder return of 25.85% points to solid longer term...

Lawmakers’ decision to relax taxes on specific remittance transfers has put Remitly Global (RELY) in focus, as investors consider how this policy shift could influence the company’s cross border payments business and stock performance. See our latest analysis for Remitly Global. Remitly Global’s share price has pulled back 4.36% over the last day to $24.13 but still shows strong momentum, with a 30 day share price return of 18.11% and year to date share price return of 82.53%, alongside a 1...

Regency Centers stock has delivered a 55.4% return over the past 5 years, and both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples currently point to the shares trading below what those models suggest, yet the broader valuation checks send a more mixed signal. With the share price recently closing at US$82.68, the question is how much room is left before that apparent discount is fully reflected. Regency Centers has returned 55.4% over 5 years, which puts...

IPG Photonics (IPGP) has drawn fresh attention after signing a binding offer to acquire Lumibird Medical, a move that would expand its medical laser business and reshape the mix of its Advanced Solutions revenue. See our latest analysis for IPG Photonics. IPG Photonics’ latest share price of $104.33 comes after a 1-day share price return of 0.94%. However, the 30-day and 90-day share price returns are down 8.19% and 16.55% respectively. The year-to-date share price return of 39.40% and 1-year...

On 8 July 2026, Globant announced a multi-year alliance with Vercel to deploy AI-built applications and modernize enterprise websites and apps via AI Pods, enabling rapid, secure, and scalable launches on Vercel’s platform. This partnership highlights how combining Globant’s AI Pods with Vercel’s infrastructure could materially compress deployment timelines, making AI-driven modernization more accessible for large organizations. We’ll now examine how Globant’s new Vercel-powered AI Pods,...

Investor attention on Atmos Energy (ATO) is picking up ahead of its next quarterly report, as the company’s pattern of topping earnings estimates and its strong dividend growth record put the current valuation debate in sharper focus. See our latest analysis for Atmos Energy. At a share price of $177.68, Atmos Energy has seen its 30 day share price return rise 4.74%, while its 1 year total shareholder return of 15.95% and 5 year total shareholder return of 102.25% highlight how recent...

With inflation cooling but still above target in many regions and energy markets influenced by geopolitical tensions, investors are looking for leaders who are directly aligned with shareholders. Founder led companies often have higher capital efficiency and meaningful personal stakes, which can be appealing when growth signals are mixed across the United States, Europe, Latin America and Asia-Pacific. This Top Founder-Led Companies screener focuses on businesses where the original builder is...

Earlier this month, Kaplan Fox & Kilsheimer LLP began investigating Alignment Healthcare after a former executive alleged accounting irregularities, including misclassifying millions of dollars of operating expenses as capital expenditures and inflating key metrics such as Adjusted EBITDA. The whistleblower-driven probe raises questions about the reliability of previously reported financial metrics that underpinned market confidence in Alignment Healthcare’s performance and efficiency. Now...

In July 2026, Nextpower Inc. asked stockholders to approve amendments to its Second Amended and Restated Certificate of Incorporation, including removing legacy Class B common stock, eliminating outdated provisions, and renaming its Class A common stock at the August 18, 2026 annual meeting. This clean‑up of the capital structure highlights management’s focus on simplifying the equity base, which can matter for governance, liquidity, and long‑term investor appeal. Next, we’ll examine how...

QuinStreet (QNST) has drawn investor attention after recent share price moves, with the stock now around $16.78 and showing mixed short term performance, alongside stronger returns over the past month and past three months. See our latest analysis for QuinStreet. Recent trading in QuinStreet points to building momentum, with a 30 day share price return of 31.4% and a year to date share price return of 19.18%, set against a 3 year total shareholder return of 86.44% and a 5 year total...

AI related stocks are drawing much of the market’s attention right now, which can leave solid, profitable companies trading on valuations that still look reasonable. That is exactly where a Growth at a Reasonable Price approach can help you focus on businesses with positive earnings profiles and measured risk, without chasing the most crowded trades. This article looks at how the current AI driven rotation interacts with fundamental metrics like P/E and PEG ratios, and highlights three stocks...

Rising geopolitical tensions, questions around US policy, and heavy use of monetary and fiscal stimulus are pushing many investors toward large cap US stocks that look reasonably priced and pay dividends. Instead of chasing the AI boom or trying to guess the next hot trend, this article focuses on value oriented blue chips that may hold up when sentiment swings. Using a US Large Cap Value Stocks screener built around the latest macro shocks, the sections that follow highlight 3 stocks that...

Earlier this month, Clover Health Investments reported that a hacker used social engineering to access three non-managerial employee accounts on July 4, exposing some personal and protected health information but not its core financial or claims systems. The incident highlights how frontline operational roles, such as visit schedulers and broker-facing staff, can become critical entry points for attackers seeking sensitive member data. We’ll now examine how this cybersecurity breach,...

Cigna Group has delivered a 32.5% gain over the past five years, yet with the stock recently closing at US$281.45, the valuation checks still point to the shares looking inexpensive rather than fully priced in. Over five years, Cigna Group is up 32.5%, which is a steady outcome that does not on its own suggest the stock has been bid up aggressively. The company’s long term valuation can be shaped by how reliably it converts revenue into cash and how effectively it manages healthcare cost...